BIOINDUSTRY · R&D SERVICES

Microbial strain development

A strain that performs in a flask and a strain that performs in a fermenter are rarely the same organism. Strain development is the work of closing that gap: isolating, improving and characterising a microorganism until its behaviour is reproducible at the scale you need it.

Talk to us about your strain
WHERE IT STARTS

Three different problems, one name

"Strain development" covers work that begins from very different points. Which one you are in decides the method, the timeline and what can honestly be promised.

You have no strain yet

The molecule is defined, the producer is not. Isolation and screening from collections or from environmental sources, then selection on the criterion that actually matters for your process — often not the highest titre, but the most stable producer.

You have a strain that underperforms

Yield too low, by-products too high, or a titre that does not survive scale-up. Improvement through mutagenesis and selection, or by changing the conditions around the organism rather than the organism itself.

You have a strain that must be documented

It works, but nobody can show why or prove it will keep working. Characterisation, stability over generations, and the analytical set that turns an organism into an asset you can defend.

How a project runs

Three stages, each ending in a decision rather than a report. How long each takes depends on the organism and on how far the starting point is from the target — we size it after the first conversation, not before.

Stage one

Proof of concept

Can this organism do what the process needs? Screening, first cultivations, a titre measured with a method we trust. The output is a go or no-go, and when it is no-go we say so early rather than spend the budget finding out slowly.

Stage two

Optimisation

Mutagenesis and selection where the genetics are the limit, medium and conditions where they are not. Each round is measured against the same analytical baseline, so an improvement is an improvement and not a difference in how it was assayed.

Stage three

Industrialisation

Behaviour in a fermenter rather than a flask, stability of the strain over generations, reproducibility between batches, and the conditions written down well enough that the result survives the move to production.

What we measure

A strain improvement is only worth what the analytics behind it can prove. These are the endpoints we report.

  • Titre and yield — product per litre and per unit of substrate, with the assay declared
  • Productivity — the same number against time, which is what the plant actually pays for
  • By-product profile — what else the organism makes, because it is usually the downstream that pays for it
  • Growth behaviour — kinetics, lag, substrate consumption, oxygen demand
  • Genetic stability — performance held over generations, not measured once on a fresh vial
  • Reproducibility — the same conditions repeated, with the spread declared rather than the best run reported
  • Robustness — how far conditions can drift before the strain stops delivering
  • Scale behaviour — what changes between flask, bench and pilot, which is where most projects find their surprise

The laboratory behind it

Equipment

Molecular biologyExtraction, PCR and qPCR, cloning and vector construction, sequence verification and sequencing, up to the whole genome where needed
CultureShake flasks and deep-well for screening, bench bioreactors; CHO cell culture, from screening formats up to the 100-litre scale
StorageCryopreservation and storage at −80 °C, with identity, viability and purity checks on every bank
AnalyticsSDS-PAGE, SEC, Bradford, HPLC and UPLC, activity assays according to the target

What you take away

StrainThe improved strain itself, characterised and with its performance documented
DossierData, conditions tested and results, in the form your technical file needs
Pilot batchProduction at scale when the project reaches that point

Frequently asked questions

How is an industrial strain improved?

Through screening, selection, mutagenesis and evolution, choosing the route according to the product and the process.

How do you show that the strain has improved?

With analytics, batch after batch: yield, productivity and whether the result holds over the following generations.

Is the improved strain preserved?

Yes, through identification and cell banking of the strain, which make it reproducible over time.

Do you provide strain engineering and cell banking for GMP manufacturing?

Strain engineering and cell banking, yes: isolation and screening, improvement by mutagenesis and selection or by working on the conditions around the organism, then identification and banking so the strain stays reproducible. GMP manufacturing, no — we are not a GMP-certified site and we work to a GMP-like regime: a quality system certified to ISO 9001 and ISO 14001, with risk analysis and procedures covering the whole path from raw material selection to pilot scale. For strain development, cell banking and process set-up that is almost always the right regime: GMP certification is a cost that makes sense when the regulatory path demands it, not before. If you are not sure which of the two you need, that is the conversation to have at the start — finding out later means redoing the studies.

Start with the organism

Tell us what the strain has to make, where you are starting from and the scale you are aiming at. We will tell you what the first stage would look like.

Talk to us about your strain

Tell us about your project

Write to us here: the division team will get back to you.